Elevated carbohydrate antigen 125 levels in patients with aortic stenosis: Relation to clinical severity and echocardiographic parameters

Turk Kardiyoloji Dernegi Arsivi

Volumn 40, Issue 4, 2012, Pages 309-315

  Varol, Ercan ^a   Yücel, Habil ^a   Arslan, Akif ^a   Özaydin, Mehmet ^a   Erdoǧan, Doǧan ^a   Doǧan, Abdullah ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aortic valve stenosis blood complications; Biological markers; CA 125 antigen; Heart failure diagnosis

Indexed keywords

CA 125 ANTIGEN; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; AORTA PRESSURE; AORTA STENOSIS; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART PERFORMANCE; HEART VENTRICLE EJECTION TIME; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRESSURE GRADIENT; SEX RATIO; THORAX RADIOGRAPHY; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; BLOOD; CASE CONTROL STUDY; ECHOGRAPHY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

AGED; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; CA-125 ANTIGEN; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84882761322     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2012.87894     Document Type: Article

References (28)

1. Kang WD, Choi HS, Kim SM. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. Gynecol Oncol 2010;116:57-60.
2. Markman M, Petersen J, Belland A, Burg K. CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial. Oncology 2010;78:1-2.
3. Faggiano P, D'Aloia A, Antonini-Cantcrin F, Vizzardi E, Nicolosi GL, Cas LD. Tumour markers in chronic heart failure. Review of the literature and clinical implications. J Cardiovasc Med (Hagerstown) 2006;7:573-9. (Pubitemid 44350491)
4. Nägele H, Bahlo M, Klapdor R, Schaeperkoetter D, Rödiger W. CA 125 and its relation to cardiac function. Am Heart J 1999;137:1044-9. (Pubitemid 30040726)
5. D'Aloia A, Faggiano P, Aurigemma G, Bontempi L, Ruggeri G, Metra M, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 2003;41:1805-11. (Pubitemid 36584256)
6. Faggiano P, D'Aloia A, Brentana L, Bignotti T, Fiorina C, Vizzardi E, et al. Serum levels of different tumour markers in patients with chronic heart failure. Fur J Heart Fail 2005;7:57-61. (Pubitemid 40092492)
7. Kouris NT, Zacharos ID, Kontogianni DD, Goranitou GS, Sifaki MD, Grassos HE, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 2005;7:199-203. (Pubitemid 40215613)
8. Varol E, Ozaydin M, Dogan A, Kosar F. Tumour marker levels in patients with chronic heart failure. Kur J Heart Fail 2005;7:840-3. (Pubitemid 41125903)
9. Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C, Kocabas R, et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol 2003;24:172-5. (Pubitemid 37500565)
10. Duman C, Ercan E, Tengiz I, Bozdemir H, Ercan HE, Nalbantgil I. Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology 2003;100:7-10. (Pubitemid 37140412)
11. Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R, Piazza R, et al. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol 2008;128:406-12.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
13. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8. (Pubitemid 16119719)
15. Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, et al. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens 2009;23:728-34.
16. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66. (Pubitemid 26011184)
17. Sjövall K, Nilsson B, Einhorn N. The significance of scrum CA 125 elevation in malignant and non malignant diseases. Gynecol Oncol 2002;85:175-8. (Pubitemid 34304030)
18. Sevinc A, Buyukberber S, San R, Turk HM, Ates M. Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites. Anticancer Res 2000;20:1201-3. (Pubitemid 30240701)
19. Sevinc A, Buyukberber S, Sari R. Elevated serum CA-125 levels: hepatitis crascites? Gynecol Oncol 2000;76:141-2.
20. Sevinc A, Buyukberber S, Sari R, Kiroglu Y, Turk HM, Ates M. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids. Gynecol Oncol 2000;77:254-7. (Pubitemid 30317145)
21. Epiney M, Bertossa C, Weil A, Campana A, Bischof P. CA125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod 2000;15:1261-5. (Pubitemid 30335947)
22. Gullu I, Yalcin S, Tekuzman G. Tumour markers in effusions: a comparative study of tumour marker levels in sera and effusion. In: Travis CC, editor. Use of biomarkers in assessing health and environmental impacts of chemical pollutants. New York: Plenum; 1993. p. 265-72.
23. Zeimet AG, Offner FA, Marth C, Heim K, Feichtinger H, Daxenbichler G, et al. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res 1997;17:3129-31. (Pubitemid 27434874)
24. Kubonishi I, Bandobashi K, Murata N, Daibata M, Ido E, Sonobe H, et al. High serum levels of C-A125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol 1997;98:450-2. (Pubitemid 27345126)
25. Varol E, Ozaydin M, Altinbas A, Asian SM, Dogan A, Dede O. Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure. Heart Vessels 2007;22:30-3. (Pubitemid 46477187)
26. Galante A, Pietroiusti A, Vellini M, Piccolo P, Possati G, De Bonis M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82. (Pubitemid 32912714)
27. Shahi CN, Ghaisas NK, Goggins M, Foley B, Crean P, Kelleher D, et al. Elevated levels of circulating soluble adhesion molecules in patients with nonrheumatic aortic stenosis. Am J Cardiol 1997;79:980-2. (Pubitemid 27197939)
28. Kosar F, Aksoy Y, Ozguntekin G, Ozerol I, Varol E. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 2006;8:270-4. (Pubitemid 44275312)